Study: Cost of developing a new drug tops $1.1 billion

Share this article:

Much has been written about the high cost of drugs. Less has been publicized about how much it costs to get medications to market. Such costs topped $1.1 billion in the 2011-2012 season, according to a new study by Deloitte and Thomson Reuters. That's up $100 million from 2010-2011, based on an examination of a dozen leading firms.

Among the study's findings: The industry has seen a jump in approvals, with 41 between 2011 and 2012, up from 32 between 2010 and 2011. Researchers said the 41 approvals in the 2011-2012 season amounted to $211 billion in projected sales, down from the $309 billion in forecasted sales of the 32 items approved the year before. So while more drugs are getting to market, they are generating smaller returns.

Share this article:

More in Products

LeadingAge's CAST releases EHR matrix selection tool

LeadingAge's Center for Aging Services Technologies released its 2014 version of a tool to let long-term providers choose the best electronic health record for their facility.

New magnetic badges debut

New magnetic badges debut

Imprint Plus has introduced The Mighty Badge name badge kit, which allows users to create reusable but personalized badges.

Hollister Incorporated celebrates antibacterial foam dressing

Hollister Incorporated celebrates antibacterial foam dressing ...

Hollister Incorporated's new Hydrofera Blue Ready antibacterial foam dressing has been named a "Top 10 Innovation in Podiatry" according to the Podiatry Today journal, as well as a "Top Innovation ...